DORZOLAMIDE vs DOSTARLIMAB-GXLY: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DORZOLAMIDE vs DOSTARLIMAB-GXLY: Safety Overview
| Metric | DORZOLAMIDE | DOSTARLIMAB-GXLY |
|---|---|---|
| Total FAERS Reports | 3,814 | 504 |
| Deaths Reported | 8 | 55 |
| Death Rate | 0.2% | 10.9% |
| Hospitalizations | 144 | 126 |
| Average Patient Age | 65.9 yrs | 67.4 yrs |
| % Female Patients | 60.6% | 92.7% |
| FDA Approval Date | Apr 13, 2009 | N/A |
| Manufacturer | Florida Pharmaceutical Products, LLC | N/A |
| Route | OPHTHALMIC | N/A |
| Marketing Status | Discontinued | Prescription |